Potempa, Christoph; Rychlik, Reinhard - In: Health economics review 8 (2018) 30, pp. 1-11
Objective: Examine cost-driving factors of schizophrenia in Germany for patients prior- and post-switch from an oral antipsychotic therapy to aripiprazole-depot and perform a budget impact analysis (BIA) referring to the context of German health care. Methods: A single-armed, retrospective,...